SCHEMBL22005200

SCHEMBL22005200

CCCCCCCC(/C=C/C(=O)OC)CCCCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ZDHHC7 Q9NXF8 1/20 0.47
HCAR2 Q8TDS4 2/20 0.41
KEAP1 Q14145 1/20 0.41
NFE2L2 Q16236 1/20 0.41
POLB P06746 1/20 0.41
POLA1 P09884 1/20 0.41
GPR84 Q9NQS5 7/20 0.40
FFAR1 O14842 1/20 0.40
MAPT P10636 1/20 0.39
EPHX1 P07099 1/20 0.39
LCK P06239 1/20 0.39
PPARD Q03181 1/20 0.39
ZDHHC20 Q5W0Z9 1/20 0.39
ZDHHC2 Q9UIJ5 1/20 0.39
CA2 P00918 2/20 0.38
ADH1B P00325 1/20 0.38
ADH1C P00326 1/20 0.38
ADH1A P07327 1/20 0.38
ADH4 P08319 1/20 0.38
ADH7 P40394 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18723159 1.00 ZDHHC7 (0.47) ZDHHC7HCAR2KEAP1NFE2L2POLB
SCHEMBL22005512 1.00 ZDHHC7 (0.47) ZDHHC7HCAR2KEAP1NFE2L2POLB
SCHEMBL31578979 0.98 ZDHHC7 (0.46) ZDHHC7HCAR2KEAP1NFE2L2POLB
SCHEMBL26047189 0.84 ZDHHC7 (0.50) ZDHHC7HCAR2KEAP1NFE2L2POLB
SCHEMBL30914719 0.84 HCAR2 (0.45) ZDHHC7HCAR2GPR84FFAR1MAPT
SCHEMBL21694608 0.84 HCAR2 (0.45) ZDHHC7HCAR2GPR84FFAR1MAPT
SCHEMBL18723218 0.84 HCAR2 (0.45) ZDHHC7HCAR2GPR84FFAR1MAPT
SCHEMBL25808263 0.83 HCAR2 (0.44) ZDHHC7HCAR2GPR84FFAR1MAPT
SCHEMBL22627138 0.82 HCAR2 (0.46) ZDHHC7HCAR2GPR84FFAR1MAPT
SCHEMBL22465645 0.82 HCAR2 (0.46) ZDHHC7HCAR2GPR84FFAR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11129819-B2 Fumarate analogs and uses thereof RIGEL PHARMACEUTICALS, INC. (US) 2021-09-28 US disclosed
US-20200155531-A1 Fumarate Analogs and Uses Thereof MIDCAP FINANCIAL TRUST 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200155531-A1 Fumarate Analogs and Uses Thereof FH, GLS, FPGS ZDHHC7 325/4885HCAR2 737/4885KEAP1 344/4885
US-11129819-B2 Fumarate analogs and uses thereof FH, GLS, FPGS ZDHHC7 325/4885HCAR2 737/4885KEAP1 344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.